These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8710193

  • 1. Abnormal, ubiquitinated cortical neurites in patients with diffuse Lewy body disease.
    Pellisé A, Roig C, Barraquer-Bordás LI, Ferrer I.
    Neurosci Lett; 1996 Mar 15; 206(2-3):85-8. PubMed ID: 8710193
    [Abstract] [Full Text] [Related]

  • 2. Microtubule-associated protein 5 is a component of Lewy bodies and Lewy neurites in the brainstem and forebrain regions affected in Parkinson's disease.
    Gai WP, Blumbergs PC, Blessing WW.
    Acta Neuropathol; 1996 Mar 15; 91(1):78-81. PubMed ID: 8773150
    [Abstract] [Full Text] [Related]

  • 3. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr 15; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 4. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
    Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB.
    J Neurol Neurosurg Psychiatry; 1989 Nov 15; 52(11):1236-47. PubMed ID: 2556498
    [Abstract] [Full Text] [Related]

  • 5. Ubiquitin-positive CA2/3 neurites in hippocampus coexist with cortical Lewy bodies.
    Kim H, Gearing M, Mirra SS.
    Neurology; 1995 Sep 15; 45(9):1768-70. PubMed ID: 7675245
    [Abstract] [Full Text] [Related]

  • 6. Immunoreactivity profile of hippocampal CA2/3 neurites in diffuse Lewy body disease.
    Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JQ.
    Acta Neuropathol; 1994 Sep 15; 87(3):269-76. PubMed ID: 7912027
    [Abstract] [Full Text] [Related]

  • 7. Multicatalytic proteinase is associated with characteristic oval structures in cortical Lewy bodies: an immunocytochemical study with light and electron microscopy.
    Masaki T, Ishiura S, Sugita H, Kwak S.
    J Neurol Sci; 1994 Apr 15; 122(2):127-34. PubMed ID: 8021694
    [Abstract] [Full Text] [Related]

  • 8. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
    Yamaguchi K, Cochran EJ, Murrell JR, Polymeropoulos MH, Shannon KM, Crowther RA, Goedert M, Ghetti B.
    Acta Neuropathol; 2005 Sep 15; 110(3):298-305. PubMed ID: 15981014
    [Abstract] [Full Text] [Related]

  • 9. Ubiquitin-immunohistochemical investigation of atypical Pick's disease without Pick bodies.
    Iseki E, Li F, Odawara T, Hino H, Suzuki K, Kosaka K, Akiyama H, Ikeda K, Kato M.
    J Neurol Sci; 1998 Aug 14; 159(2):194-201. PubMed ID: 9741407
    [Abstract] [Full Text] [Related]

  • 10. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I, Blanco R, Carmona M, Puig B, Barrachina M, Gómez C, Ambrosio S.
    J Neural Transm (Vienna); 2001 Aug 14; 108(12):1383-96. PubMed ID: 11810403
    [Abstract] [Full Text] [Related]

  • 11. Neuritic degeneration in the hippocampus and amygdala in Parkinson's disease in relation to Alzheimer pathology.
    Mattila PM, Rinne JO, Helenius H, Röyttä M.
    Acta Neuropathol; 1999 Aug 14; 98(2):157-64. PubMed ID: 10442555
    [Abstract] [Full Text] [Related]

  • 12. Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.
    Lennox G, Lowe J, Morrell K, Landon M, Mayer RJ.
    J Neurol Neurosurg Psychiatry; 1989 Jan 14; 52(1):67-71. PubMed ID: 2540286
    [Abstract] [Full Text] [Related]

  • 13. Ubiquitin-reactive neurites in cerebral cortex of subjects with Huntington's chorea: a pathological correlate of dementia?
    Cammarata S, Caponnetto C, Tabaton M.
    Neurosci Lett; 1993 Jun 25; 156(1-2):96-8. PubMed ID: 8414198
    [Abstract] [Full Text] [Related]

  • 14. Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex.
    Tolnay M, Probst A.
    Neuropathol Appl Neurobiol; 1995 Dec 25; 21(6):492-7. PubMed ID: 8745238
    [Abstract] [Full Text] [Related]

  • 15. Dementia with Lewy bodies: neuropathology.
    Dickson DW.
    J Geriatr Psychiatry Neurol; 2002 Dec 25; 15(4):210-6. PubMed ID: 12489917
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neuropathologic evidence that the Lewy body variant of Alzheimer disease represents coexistence of Alzheimer disease and idiopathic Parkinson disease.
    Brown DF, Dababo MA, Bigio EH, Risser RC, Eagan KP, Hladik CL, White CL.
    J Neuropathol Exp Neurol; 1998 Jan 25; 57(1):39-46. PubMed ID: 9600196
    [Abstract] [Full Text] [Related]

  • 18. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.
    Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y.
    Acta Neuropathol; 1988 Jan 25; 75(4):345-53. PubMed ID: 3364159
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hippocampal pathology in diffuse Lewy body disease using ubiquitin immunohistochemistry.
    Iseki E, Li F, Odawara T, Kosaka K.
    J Neurol Sci; 1997 Aug 25; 149(2):165-9. PubMed ID: 9171325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.